...
首页> 外文期刊>Journal of anesthesia >Comparison of alcohol ablation with repeated thermal radiofrequency ablation in medial branch neurotomy for the treatment of recurrent thoracolumbar facet joint pain
【24h】

Comparison of alcohol ablation with repeated thermal radiofrequency ablation in medial branch neurotomy for the treatment of recurrent thoracolumbar facet joint pain

机译:酒精消融与反复热射频消融治疗内侧分支神经切开术治疗复发性胸腰椎小关节疼痛的比较

获取原文
获取原文并翻译 | 示例

摘要

Purpose: Chemical denervation is not recommended as part of the routine care of chronic non-cancer pain. Physicians face a dilemma when it comes to repeated interventions in cases of recurrent thoracolumbar facet joint pain after successful thermal radiofrequency ablation (RFA) in medial branch neurotomy. This study was performed to compare the effects of alcohol ablation (AA) with thermal RFA in patients with recurrent thoracolumbar facet joint pain after thermal RFA treatment. Methods: Forty patients with recurrent thoracolumbar facet joint pain after successful thermal RFA defined as a numeric rating scale (NRS) score of ≥7 or a revised Oswestry disability index (ODI) of ≥22 % were randomly allocated to two groups receiving either the same repeated RFA (n = 20) or AA (n = 20). The recurrence rate was assessed with NRS and ODI during the next 24 months, and adverse events in each group were recorded. Results: During the 24-month follow-up after RFA and AA, one and 17 patients, respectively, were without recurring thoracolumbar facet joint pain. The median effective periods in the RFA and AA groups were 10.7 (range 5.4-24) and 24 (range 16.8-24) months, respectively (p < 0.000). No significant complications were observed with the exception of injection site pain, which occurred in both groups. Conclusion: In our patient cohort, alcohol ablation in medial branch neurotomy provided a longer period of pain relief and better quality of life than repeated radiofrequency medial branch neurotomy in the treatment of recurrent thoracolumbar facet joint pain syndrome after successful thermal RFA without significant complications during the 24-month follow-up.
机译:目的:不建议将化学去神经支配作为慢性非癌性疼痛的常规治疗的一部分。当在内侧分支神经切开术成功进行热射频消融(RFA)后,复发性胸腰小平面关节疼痛的情况下,医师需要面对反复干预的困境。进行这项研究的目的是比较酒精消融(AA)和热RFA对热RFA治疗后复发性胸腰小关节疼痛的患者的影响。方法:将40例成功通过RFA成功定义为数字评分量表(NRS)评分≥7或经修订的Oswestry残疾指数(ODI)≥22%的胸腰椎小关节关节痛患者随机分为两组,每组均接受相同的治疗重复RFA(n = 20)或AA(n = 20)。在接下来的24个月内使用NRS和ODI评估复发率,并记录每组的不良事件。结果:在RFA和AA术后的24个月随访中,分别有1例和17例患者没有复发的胸腰小平面关节痛。 RFA和AA组的中位有效期分别为10.7(5.4-24)和24(16.8-24)个月(p <0.000)。除两组均发生注射部位疼痛外,未观察到明显的并发症。结论:在我们的患者队列中,成功进行RFA成功治疗后复发性胸腰椎小关节关节疼痛综合征,与反复进行射频内支神经切开术相比,在内侧分支神经切开术中进行酒精消融术可提供更长的疼痛缓解时间和更好的生活质量。 24个月的随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号